14
Participants
Start Date
February 29, 2012
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
SKY0402
Single-injection femoral nerve block. Initial doses of SKY0402 will begin at 0 mg, and 2 mg (high) for the first subject; and 1 mg (low) and 3 mg (high) for the second subject. The next doses will be between 0-80 mg per side, determined prior to randomization of each subsequent subject. The specific subsequent doses will increase, remain the same, or decrease, determined by the P.I. in consultation with the manufacturer of SKY0402. Doses will always remain within the range of 0-80 mg per side, for a total possible dose of 0-160 mg.
UCSD Medical Center Hillcrest, San Diego
Collaborators (1)
Pacira Pharmaceuticals, Inc
INDUSTRY
University of California, San Diego
OTHER